120.11
-0.58 (-0.48%)
| Previous Close | 120.69 |
| Open | 121.32 |
| Volume | 43,268 |
| Avg. Volume (3M) | 93,448 |
| Market Cap | 668,493,824 |
| Price / Earnings (TTM) | 12.36 |
| Price / Sales | 1.07 |
| Price / Book | 3.34 |
| 52 Weeks Range | |
| Earnings Date | 13 May 2025 |
| Profit Margin | 10.76% |
| Operating Margin (TTM) | 34.10% |
| Diluted EPS (TTM) | 12.35 |
| Quarterly Revenue Growth (YOY) | 214.00% |
| Total Debt/Equity (MRQ) | 124.19% |
| Current Ratio (MRQ) | 2.27 |
| Operating Cash Flow (TTM) | 71.07 M |
| Levered Free Cash Flow (TTM) | 46.11 M |
| Return on Assets (TTM) | 22.34% |
| Return on Equity (TTM) | 78.92% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Nutex Health Inc. | Bullish | Bullish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | -0.88 |
|
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 35.81% |
| % Held by Institutions | 18.53% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| One Plus One Wealth Management, Llc | 31 Dec 2024 | 37,541 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 300.00 (Benchmark, 149.77%) | Buy |
| Median | 262.50 (118.55%) | |
| Low | 225.00 (Maxim Group, 87.33%) | Buy |
| Average | 262.50 (118.55%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 175.49 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Maxim Group | 20 May 2025 | 225.00 (87.33%) | Buy | 177.21 |
| 08 Apr 2025 | 100.00 (-16.74%) | Buy | 84.94 | |
| Benchmark | 15 May 2025 | 300.00 (149.77%) | Buy | 173.76 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 27 Jun 2025 | Announcement | NUTEX HEALTH ANNOUNCES THAT IT HAS FILED A SUPPLEMENT TO ITS PROXY STATEMENT |
| 24 Jun 2025 | Announcement | NUTEX HEALTH INC. ADDED TO RUSSELL 3000® INDEX AND RUSSELL MICROCAP® INDEX |
| 02 Jun 2025 | Announcement | NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING |
| 22 May 2025 | Announcement | NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR |
| 13 May 2025 | Announcement | NUTEX HEALTH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS |
| 07 May 2025 | Announcement | Nutex Health Schedules 2025 First Quarter Financial Results Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |